4-Substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine Derivatives: Design, Synthesis, Antitumor and EGFR Tyrosine Kinase Inhibitory Activity

被引：19

作者：

Abbas, Safinaz E. -S. ^{[1
]}

Aly, Enayat I. ^{[1
]}

Awadallah, Fadi M. ^{[1
]}

Mahmoud, Walaa R. ^{[1
]}

机构：

[1] Cairo Univ, Dept Pharmaceut Chem, Fac Pharm, Cairo 11562, Egypt

来源：

CHEMICAL BIOLOGY & DRUG DESIGN | 2015年 / 85卷 / 05期

关键词：

antitumor; EGFR-TK inhibition; molecular modeling; pyrazolo[3; 4-d]pyrimidines; synthesis; ANTIPROLIFERATIVE ACTIVITY; CANCER; AGENTS; STRATEGY; DOCKING; CELLS; A431;

D O I：

10.1111/cbdd.12451

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Four series of some 4-substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives 5a-f, 6a-f, 8a-f, and 9a-f were designed to be screened for their antitumor activity. All compounds were evaluated against breast (MCF-7) and lung (A-549) cell lines. Six compounds 5a, 5b, 6b, 6e, 9e, and 9f displaying activity against both cell lines were further estimated for their EGFR-TK inhibitory activity where they revealed 41-91% inhibition and compound 6b elicited the highest activity (91%). A docking study of these compounds into the ATP-binding site of EGFR-TK demonstrated their binding mode where H-bonding interaction with Met793 through N-1 of pyrimidine or N-2 of pyrazole was observed.

引用

页码：608 / 622

页数：15

共 34 条

[11] Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation [J].

Carraro, F ;

Naldini, A ;

Pucci, A ;

Locatelli, GA ;

Maga, G ;

Schenone, S ;

Bruno, O ;

Ranise, A ;

Bondavalli, F ;

Brullo, C ;

Fossa, P ;

Menozzi, G ;

Mosti, L ;

Modugno, M ;

Tintori, C ;

Manetti, F ;

Botta, M .

JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (05) :1549-1561

[12] POTENTIAL PURINE ANTAGONISTS .6. SYNTHESIS OF 1-ALKYL-4-SUBSTITUTED AND 1-ARYL-4-SUBSTITUTED PYRAZOLO[3,4-D]PYRIMIDINES [J].

CHENG, CC ;

ROBINS, RK .

JOURNAL OF ORGANIC CHEMISTRY, 1956, 21 (11) :1240-1256

[13] THE ERLENMEYER REACTION WITH ALIPHATIC ALDEHYDES, 2-PHENYLOXAZOL-5-ONE BEING USED INSTEAD OF HIPPURIC ACID [J].

CRAWFORD, M ;

LITTLE, WT .

JOURNAL OF THE CHEMICAL SOCIETY, 1959, (FEB) :729-731

[14] Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling [J].

Donnini, Sandra ;

Monti, Martina ;

Castagnini, Cinzia ;

Solito, Raffaella ;

Botta, Maurizio ;

Schenone, Silvia ;

Giachetti, Antonio ;

Ziche, Marina .

INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (05) :995-1004

[15] Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors [J].

Ducray, Richard ;

Ballard, Peter ;

Barlaam, Bernard C. ;

Hickinson, Mark D. ;

Kettle, Jason G. ;

Ogilvie, Donald J. ;

Trigwell, Catherine B. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) :959-962

[16]

Guvigny P. T., 1961, B SOC CHIM FR, P2423

[17] Small Molecule Inhibitors of AKT/PKB Kinase as a Strategy for Treating Cancer [J].

Heerding, Dirk A. ;

Safonov, Igor G. ;

Verma, Sharad K. .

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42, 2007, 42 :365-376

[18]

Ingersoll A. W., 1943, ORG SYN COLL, V2, P328

[19] Signaling networks: The origins of cellular multitasking [J].

Jordan, JD ;

Landau, EM ;

Iyengar, R .

CELL, 2000, 103 (02) :193-200

[20] Synthesis and biological evaluations of pyrazolo[3,4-d] pyrimidines as cyclin-dependent kinase 2 inhibitors [J].

Kim, DC ;

Lee, YR ;

Yang, BS ;

Shin, KJ ;

Kim, DJ ;

Chung, BY ;

Yoo, KH .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (05) :525-532

← 1 2 3 4 →